1496 / 1983
Background and Purpose
•
Because tumors in
BRCA
mutation carriers might be more
sensitive to radiation with increased risk of second primaries, we
report after long term follow-up whether mutation status
influenced the rate of ipsilateral tumors after breast-conserving
treatment.
•
A case-control study was performed